The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
Clearing 19 biologics for Europe market
The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity
Marketing leader behind growth of brands such as Cipladine, Maxirich, and Soak Shield takes on expanded responsibilities to drive portfolio growth and consumer engagement.
.jpeg)
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
